Pseudomonas aeruginosa Phenotypes Associated With Eradication Failure in Children With Cystic Fibrosis

被引:62
|
作者
Mayer-Hamblett, Nicole [1 ,2 ,6 ]
Ramsey, Bonnie W. [1 ,6 ]
Kulasekara, Hemantha D. [3 ]
Wolter, Daniel J. [1 ]
Houston, Laura S. [1 ]
Pope, Christopher E. [1 ]
Kulasekara, Bridget R. [3 ]
Armbruster, Catherine R. [3 ]
Burns, Jane L. [1 ,6 ]
Retsch-Bogart, George [7 ]
Rosenfeld, Margaret [1 ,6 ]
Gibson, Ronald L. [1 ,6 ]
Miller, Samuel I. [3 ,4 ,5 ]
Khan, Umer [6 ]
Hoffman, Lucas R. [1 ,3 ,6 ]
机构
[1] Univ Washington, Dept Pediat, Seattle, WA 98105 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98105 USA
[3] Univ Washington, Dept Microbiol, Seattle, WA 98105 USA
[4] Univ Washington, Dept Genome Sci, Seattle, WA 98105 USA
[5] Univ Washington, Dept Med, Seattle, WA 98105 USA
[6] Seattle Childrens Hosp, Washington, DC USA
[7] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA
基金
美国国家卫生研究院;
关键词
cystic fibrosis; Pseudomonas aeruginosa; phenotypic characterization; eradication; antibiotic treatment; YOUNG-CHILDREN; COLONY MORPHOLOGY; LUNG-FUNCTION; LASR MUTANTS; INFECTION; ADAPTATION; TOBRAMYCIN; DISEASE; AIRWAYS; DIVERSIFICATION;
D O I
10.1093/cid/ciu385
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Pseudomonas aeruginosa is a key respiratory pathogen in people with cystic fibrosis (CF). Due to its association with lung disease progression, initial detection of P. aeruginosa in CF respiratory cultures usually results in antibiotic treatment with the goal of eradication. Pseudomonas aeruginosa exhibits many different phenotypes in vitro that could serve as useful prognostic markers, but the relative relationships between these phenotypes and failure to eradicate P. aeruginosa have not been well characterized. Methods. We measured 22 easily assayed in vitro phenotypes among the baseline P. aeruginosa isolates collected from 194 participants in the 18-month EPIC clinical trial, which assessed outcomes after antibiotic eradication therapy for newly identified P. aeruginosa. We then evaluated the associations between these baseline isolate phenotypes and subsequent outcomes during the trial, including failure to eradicate after antipseudomonal therapy, emergence of mucoidy, and occurrence of an exacerbation. Results. Baseline P. aeruginosa isolates frequently exhibited phenotypes thought to represent chronic adaptation, including mucoidy. Wrinkly colony surface and irregular colony edges were both associated with increased risk of eradication failure (hazard ratios [95% confidence intervals], 1.99 [1.03-3.83] and 2.14 [1.32-3.47], respectively). Phenotypes reflecting defective quorum sensing were significantly associated with subsequent mucoidy, but no phenotype was significantly associated with subsequent exacerbations during the trial. Conclusions. Pseudomonas aeruginosa phenotypes commonly considered to reflect chronic adaptation were observed frequently among isolates at early detection. We found that 2 easily assayed colony phenotypes were associated with failure to eradicate after antipseudomonal therapy, both of which have been previously associated with altered biofilm formation and defective quorum sensing.
引用
收藏
页码:624 / 631
页数:8
相关论文
共 50 条
  • [41] The Approach to Pseudomonas aeruginosa in Cystic Fibrosis
    Talwalkar, Jaideep S.
    Murray, Thomas S.
    CLINICS IN CHEST MEDICINE, 2016, 37 (01) : 69 - +
  • [42] Pseudomonas aeruginosa biofilms in cystic fibrosis
    Hoiby, Niels
    Ciofu, Oana
    Bjarnsholt, Thomas
    FUTURE MICROBIOLOGY, 2010, 5 (11) : 1663 - 1674
  • [43] MICROBIOLOGICAL FEATURES OF PSEUDOMONAS AERUGINOSA IN CHILDREN WITH CYSTIC FIBROSIS
    Ishchenko, O., V
    Stepanskyi, D. O.
    MEDICNI PERSPEKTIVI, 2021, 26 (03): : 131 - 138
  • [44] Antibody Response to Pseudomonas aeruginosa in Children With Cystic Fibrosis
    Milagres, Lucimar G.
    Castro, Tatiana L. A.
    Garcia, Daniely
    Cruz, Aline C.
    Higa, Laurinda
    Folescu, Tania
    Marques, Elizabeth A.
    PEDIATRIC PULMONOLOGY, 2009, 44 (04) : 392 - 401
  • [45] Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time
    Crull, Mathew R.
    Ramos, Kathleen J.
    Caldwell, Ellen
    Mayer-Hamblett, Nicole
    Aitken, Moira L.
    Goss, Christopher H.
    BMC PULMONARY MEDICINE, 2016, 16
  • [46] Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis
    Langan, Katherine M.
    Kotsimbos, Tom
    Peleg, Anton Y.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (06) : 547 - 556
  • [47] Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosis
    Sherrard, Laura J.
    Wee, Bryan A.
    Duplancic, Christine
    Ramsay, Kay A.
    Dave, Keyur A.
    Ballard, Emma
    Wainwright, Claire E.
    Grimwood, Keith
    Sidjabat, Hanna E.
    Whiley, David M.
    Beatson, Scott A.
    Kidd, Timothy J.
    Bell, Scott C.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : E35 - E43
  • [48] Association of Pseudomonas aeruginosa infection stage with lung function trajectory in children with cystic fibrosis
    Rosenfeld, Margaret
    Faino, Anna, V
    Qu, Pingping
    Onchiri, Frankline M.
    Blue, Elizabeth E.
    Collaco, Joseph M.
    Gordon, William W.
    Szczesniak, Rhonda
    Zhou, Yi-Hui
    Bamshad, Michael J.
    Gibson, Ronald L.
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (05) : 857 - 863
  • [49] Early detection using qPCR of Pseudomonas aeruginosa infection in children with cystic fibrosis undergoing eradication treatment
    Blanchard, Ana C.
    Rooney, Ashley M.
    Yau, Yvonne
    Zhang, Yu
    Stapleton, Patrick J.
    Horton, Eric
    Klingel, Michelle
    Stanojevic, Sanja
    Ratjen, Felix
    Coburn, Bryan
    Waters, Valerie
    JOURNAL OF CYSTIC FIBROSIS, 2018, 17 (06) : 723 - 728
  • [50] Hydrogen Cyanide as a Biomarker for Pseudomonas Aeruginosa in the Breath of Children With Cystic Fibrosis
    Enderby, Beth
    Smith, David
    Carroll, W.
    Lenney, W.
    PEDIATRIC PULMONOLOGY, 2009, 44 (02) : 142 - 147